In this paper, we describe a simple catalyst-free protocol for the synthesis of thiazole, thiazolone integrated pyrazole derivatives, under ultra-sonication technique. Thiazolone derivatives (5a, 5e, 5i, 5d, 5h, 5l)were derived from [3+2] cyclocondensation reaction between carbothioamide pyrazoline (4a-c) as S-N bi-nucleophile with DMAD/DEAD. The target molecules (5b, 5f, 5j,5c, 5g, 5k)were synthesized by the reaction of (4a-c) with the substituted bromoethanone. Formation of the products was confirmed by FT-IR, 1 H-NMR, 13 C-NMR, LC-MS analysis. Docking studies were carried out against the antimicrobial target (Acinetobacterbaumannii penicillin) to know the interaction of the molecules (ligands) with the docked target. Among the docked compounds thiazolone derivative ( 5d) showed theminimum binding energy of -9.08 kJ/mol with ligand efficiency of -0.23. All the synthesized compounds were examined primarily for their in-vitro antibacterial and antioxidant activity (IC 50 ). Compound (5g)(18±0.0) and (5d)(19.5±0.5) showed significant bacterial inhibition against E.coli and S.aureus. Compound (5k) (16.57) showed substantially DPPH free radical inhibition activity as compared to the reference drug Ascorbic acid.
Introduction
The importance of heterocycles and modified heterocycles in living system is well known for curing many chronic diseases. [1] [2] Nowadays the treatment of bacterial and fungal infectious diseases remains a challenging problem because of the increasing number of multi-drug resistant microbial pathogens. Designing new compounds with an active nucleus to deal with multidrug-resistant bacteria are one of the challenging work for the chemist in the field of medicinal chemistry, among them, heterocycles are the fundamental core for the inhibition of many fatal diseases. [3] [4] Incorporation of five-membered heterocycles is always a fascinating work for the chemist, due to its potentiality as a therapeutic agent.
antidiabetics, 6 antimicrobial, 7-8 tubercular, 9 antioxidant, 10 antiinflammatory 11 etc. Among these, thiazole and thiazolone are building blocks for several natural products as they are mainly found in Vitamin B 1 (thiamine). They are also found in many biological active drugs such as sulfathiazole (anti-microbial), abafungin (antifungal), meloxicam (anti-inflammatory), tiazofurin (anti-neoplastic). Pharmacological studies showed that incorporation of thiazole nucleus increases the biological activity. [12] [13] Apart from thiazole/thiazolone, drugs bearing pyrazole, pyrazoline, and thiophene showed enhanced activity after the introduction of these heterocycles [14] [15] . Ultrasoundmediated organic synthesis has had a significant impact on synthetic chemistry like reduction in reaction time, increase in the product yield and suppression of side product formation over the conventional thermal method [16] [17] . Prompted by these observations and in our search for green techniques [18] [19] [20] , we prepared twelve new heterocyclic hybrid-templets carrying thiazole, thiazolone, pyrazole, pyrazoline, thiophene and sydnone moieties by catalyst-free ultra-sonication technique. All newly synthesized compounds (4a-c) and (5a-l) were initially assessed for their interaction with the antimicrobial target (Acinetobacterbaumannii penicillin) and we further evaluated for their in-vitro antibacterial activity against clinical isolates. Radical scavenging ability of the compounds was also carried out against DPPH radical. The structure of the newly synthesized compounds were established on the basis of FT-IR, 1 H-NMR, 13 C-NMR, LC-MS data and X-ray analysis.
Experimental

Material, Methods and Instrumentation
All the chemicals were purchased from Sigma-Aldrich or HiMedia and used after distillation/ recrystallization. The ultrasound-assisted synthesis was carried out using catalyst system Mini-M operator.
1 H NMR and 13 C NMR spectra were recorded on a 400 MHz Bruker Avance II NMR spectrometer with CDCl 3 (Deuterated chloroform) and TMS (tetramethylsilane) as an internal standard. Mass spectra were recorded on LC-MS (SHIMADZU LCMS-8030) operating at 70 eV. The X-ray diffraction of compound (5e)obtained with Rigaku Saturn724+ diffractometer with graphite monochromatedMoKa radiation at 296 K. Melting points was observed with Innovative DTC-967A digital melting point device. FT-IR spectra were recorded by dispersing the compounds in potassium bromide pellets on a Shimadzu FT-IR 157 spectrophotometer. The molecular docking was performed and analyzed using AutoDock 4.2.The Bacterial isolates Staphylococcus aureus(NCIM-5021),Bacillus subtilis (NCIM-2197), Escherichia coli (NCIM-2931), and Pseudomonas aeruginosa (NCIM-2036)were obtained from the National collection of industrial microorganisms, Pune, India. The purity of the compounds was checked on silica gel plates (Merck) and visualized under ultraviolet lamp using ethyl acetate: hexane (3:7) as a mobile phase. To a mixture of 3-methyl-5-aryloxy-1-phenyl-1H-pyrazole-4-carbaldehyde (1 a-c) [21] [22] (0.01 mol) and acetyl thiophene (2) (0.01 mol) in 25 mL of ethanol, pottasium hydroxide (0.5g, 0.01 mol) in 5 mL ethanol was added drop wise under ice bath, and the mixture was stirred for 4 hours. After the completion of the reaction (monitored by TLC), the solid product separated was filtered, washed with water, dried and recrystallized from ethanol: dimethylformamide mixture. (Table 1) .
General procedure for the preparation 2-(2-(5-(3-methyl-5-aryloxy-1-phenyl-1H-pyrazol-4-yl)-3-(thiophen-2-yl)-4,5-dihydropyrazol-1-yl)-4-oxothiazol-5(4H)-ylideneacetate(5a, 5e, 5i, 5d, 5h, 5l)
A mixture of thiocarboamide(4a-c) (0.01 mol) andDMAD (dimethyl acetylenedicarboxylates) or DMED (diethyl acetylenedicarboxylates) (0.01 mol) was taken in 50 mL of round-bottomed flask and added 25 mL of ethanol. The resulting mixture was treated under ultra-sonication for the appropriate time ( Table 1 ). The solid product separated was filtered, washed with water, dried and recrystallized from ethanol-dimethylformamide mixture.
General procedure for the preparation 5-(1-phenyl-3-methyl-5-aryloxy-1H-4-pyrazolyl)-3-(2-thiophenyl)-1-(4-substituted-thiazole-2-yl)-4,5-dihydro-1H-pyrazol)(5b, 5f, 5j,5c, 5g, 5k)
A mixture of compounds ( 4a-c) and p-bromophencyl bromide/ 4-bromoacetyl-3-(p-tolyl) sydnone(0.01 mol) was taken in 50 mL round-bottomed flask and dissolved by adding 25mL of ethanol. The resulting mixture was treated under ultrasonication for the appropriate time ( Table 1 ). The solid product was separated, filtered, washed with water and dried and, then the obtained products were further purified by recrystallization from aqueous ethanol: DMF mixture. The 
Biological Activity
Antioxidant activity
The free radical scavenging activity of the title compounds is measured by using 2, 2-diphenyl-1-picrylhydrazyl (DPPH) method 23 . 0.2mM solution of DPPH in methanol was prepared, and 100μl of this solution was added to various concentrations oftitle compoundsat the concentrations of 10, 20, 30, 40, 50 μg/ml. After 30 minutes, absorbance was measured at 517nm. Ascorbic acid was used as the reference material. All the tests were performed in triplicate and percentage of inhibition was calculated by comparing the absorbance values of the control and test samples.
Antibacterial activity
The antibacterial activity of the synthesized thiocarbamide intermediate (4a-c), thiazole and thiazolone derivatives (5a-l) was tested against bacterial isolates Staphylococcus aureus(NCIM-5021),Bacillus subtilis (NCIM-2197) (Grampositive bacteria), Escherichia coli (NCIM-2931), and Pseudomonas aeruginosa (NCIM-2036) (Gram-negative bacteria) by cup-plate method 24 at 50 µg/mL concentration.The sterilized nutrient agar medium was distributed 100 mL each in two 250 mL conical flasks and allowed to cool to room temperature. To these media, 18-24 hr grown bacterial sub-cultures were added and shaken thoroughly to ensure uniform distribution of organismthroughout the medium. Then, this agar medium was distributed in equal portions, in sterilized Petri dishes, ensuring that each Petri dish contains about 45-50 mL of the medium. The medium was then allowed for solidification. Then, cups were made with the help of a sterile cork borer (6 mm diameter) punching into the set of agar media. The solutions of required concentrations (50 µg/mL) of test compounds were prepared by dissolving the compounds in DMF and were filled into the cups with 1mL of particular solution. Then, the Petri dishes were kept for incubation in an inverted position for 48 hr at 37 0 C in an incubator. When growth inhibition zones were developed surrounding each cup, their diameter in mm was measured and compared with that of the standard drug Ciprofloxacin.
Molecular Docking Studies
Energy minimization for ligands was carried out using Dundee PRODRG server [25] [26] and the protein target which was retrieved from the RCSB protein data Bank (PDB Code 3UDI) served as a docking receptor. The binding interaction between macromolecule and ligands was done using AutoDock 4.2.The molecular docking was performed and analyzed using AutoDock 4.2. A Lamarckian genetic algorithm method implemented in the program suite was employed to identify appropriate binding modes and conformation of the ligand molecules. Gasteiger charges were added, and the AutoDock tools set the rotatable bonds,and all torsions were allowed to rotate. Polar hydrogen atoms were added, and Kollaman charges were assigned to the protein using AutoDock tools (ADT).
Result and Discussion
Chemistry
The synthetic route for thiazole, thiazolone integrated pyrazole pyrazoline, and thiophene derivative is limned in (Scheme 1 ) .Reaction of5-(3-methyl-5-aryloxy-1-phenyl-1H- 5a, 5e, 5i and 5d, 5h, 5l) . Also, compounds (4a-c) on treatment with p-bromophencylbromide and 4-bromoacetyl-3-(p-tolyl) sydnone lead to the formation of thiazole derivatives ( 5b, 5f, 5j) and ( 5e, 5g, 5k) in moderate to excellent yield under ultra-sonication method Ar= Phenyl, o-Tolyl, 2,4-Dichloro phenyl Scheme 1:Synthetic route for the synthesis of thiazole/thiazolone derivatives Formation of thiazole and thiazolone hybrid from pyrazoline carbothioamide ( 4a-c) was confirmed by the changes observed in the 1 H-NMR, 13 C-NMR, LC-MS, FT-IR, Mass and X-ray analysis. In the FT-IR spectrum of compound (5a),the absence of NHbandat 3398 cm -1 and disappearance of C=S stretching vibration at 1373 cm -1 firmly indicate the formation of cyclized product (5a). It is also supported by the appearance of strong stretching bands around 1738 cm -1 & 1698 cm -1 for ester carbonyl, as well as cyclic ring carbonyl in the compounds, that confirm the formation of [3+2] cyclo condensation product ( 5a). In the FT-IR spectrum of compound ( 5b)absence of NH 2 , C=S and C=O stretching indicate the formation thiazole nucleus. Molecules carrying mesoionic compounds (5c) shows a strong peak at 1729 cm -1 corresponding to the lactone ring in sydnone moiety.
Formation of title compounds was also confirmed by the 1 H-NMR spectrum (Fig. 1) . The signal due to the NH 2 protons of carbothioamide intermediate (4a) disappeared in the spectrum of compounds (5a). In the target compound (5a) the singlet at 3.84 ppm integrating for 3 protons indicates the presence of methoxy protons and confirmes the [3+2] cyclocondensation with dimethyl acetylene dicarboxylate (DMAD). The peaks at 2.48 ppm as singlet corresponding to the pyrazole methyl protons. The proton in pyrazoline ring displayed ABX pattern of signals corresponding to diastereotopic methylene and chiral methine protons. The geminal protons H A and H B appeared in the region 3.47 and 3.77 ppm as two doublet of the doublet. The chiral proton showed vicinal coupling with magnetically non-equivalent geminal protons in the region 5.64 ppm as doublet of doublet. The C2-H proton of thiophene appeared as a doublet at 6.59 ppm. The aromatic protons appeared in the region 6.88-7.55 ppm as multiplet.
Fig. 1.
1 H NMR spectrum of compound (5a) Fig. 2 . 13 C-NMR spectrum of compound (5a)
The 13 C-NMR and LC-MS analysis further confirmed the structure of the thiazole and thiazolone derivatives. In 13 C-NMR spectra of title compounds (5a) (Fig. 2) The formation of the products (5a-l) were also supported by the single crystal X-ray diffraction method. The thiazolone derivative (5e) were crystallized into a single crystal by the slow evaporation technique. The crystal structure of compound ( 5e) provides solid evidence for thestereoselectivity (Z -isomer) in the reaction. During the cycloaddition between dienophile (DMAD/DMED) with S-N bi-nucleophile, the thiocarbamide sulfur was added to dienophile in trans manner and finally the proton transfer to the formed carbanion resulted in the formation of free imine.
The intramolecular attack of imine to one of the ester group (since it is symmetrical alkyne) under ultrasonication resulted in the formation of thiazolone derivatives ( 5a-l) with stereoselectively Z-configuration of the exocyclic double bond. The stereoselectivity is believed due to the trans addition of SH group (Scheme. 2) to the triple bond in DMAD/DMED. The ortep diagram of the compound is given in (Fig. 3) . The details of crystal structure and data refinement are given in (Table 2 ).
Trans addition of sulfur
Intramolecular attack of imine to ester [3+2] cyclocondensation Z-isomer Intermolecular attack of sulfur to dienophile H-Transfer
Scheme 2: A reasonable mechanism for the stereoselectivity in the reaction (Z-isomer) Crystal system monoclinic Space group P2 1 /n Fig. 3 . Single crystal X-ray structure of compound (5e) showing the atomic numbering system. Displacement ellipsoids are drawn at the 50% probability.
Antioxidant activity
The results obtained from the DPPH radical inhibition assay are presented in the ( Table 3 ) .Compound ( 5k)(16.57) exhibited excellent radical inhibition activity, even greater than standard ascorbic acid (18.21) . As compared to key intermediates (4a-c), DPPH radical inhibition activity was enhanced by the introduction of thiazole and thiazolone derivatives (5a-l). 
Molecular Docking
In molecular docking study, all of the compounds (4a-c) and (5a-l) were found to have minimum binding energy ranging from -4.17 to -9.08 kJ/mol. Among the molecules tested for docking study, (5d)showed the minimum binding energy of -9.08 kJ/mol with ligand efficiency of -0.23. Most of the residues that are near the inhibitor are hydrophobic in nature. The ligand molecules, ( 5h)(5l) and ( 5a) revealed binding energy of -8.08, -8.00 and -7.76 kJ/mol, with ligand efficiency of -0.20, -0.19 and -0.19, respectively. These molecules were wrapped entirely by active site amino acid residues at the active site pocket region (Fig S 1. Supplemental materials) . Similarly, molecules (5d, 5e, 5a) and (4c)were found to show hydrogen bond interaction with active site amino acid residues, THR670, THR672, GLY709, THR670, THR672, LYS669, THR670 and TYR485, THR670, at a distance of (1.86, 2.24) (1.72, 2.14), (1.78, 2.11) and (2.154, 2.159) Å, respectively as depicted in (Fig. 2) . The docking study results showed that the molecules (5a-l)and (4a-c)have an excellent inhibition constant, vdW + Hbond + dissolve energy with best RMSD value. Docking studies showed that thiazole, thiazolone derivatives are an excellent inhibitor of the bacterial target. The details of docked score results of the molecules with antimicrobial protein target (PDB Code: 3UDI)are given in(Table S I supplemental materials)and binding mode of molecules presented in (Fig S 2 . Supplemental materials) Fig 2. Fig (a) and (b) represents the H-bond interaction of ligand molecules 5d, 5h, with 3UDI.
5.Conclusions
In summary, we have reported eco-friendly synthesis of thiazole and thiazolone derivatives through [3+2] cyclocondensation and Hantzsch cyclization. The structures of these compounds were confirmedbyanalytical, spectral and X-ray crystallographic analysis. Docking studies showed their suitability as antibacterial agents, this was in turn supported by in-vitro antibacterial activity. Antioxidant studies showed that some of the synthesized compounds exhibited excellent DPPH radical inhibition activity comparable to that of standard ascorbic acid. The overall study manifests the importance of modified heterocyclic systems in biological activity (antibacterial and antioxidant activity).
